Steven Cohen’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRO
Steven Cohen's SPRO Position: Q3 2026 in Review
Steven Cohen reduced its Spero Therapeutics (SPRO) stake by 86% in Q3 2026, selling an estimated $122K and leaving 14,639 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3811.
Steven Cohen first reported a position in SPRO in Q3 2018 and has held it in 5 quarters since. The position peaked at $462K in Q3 2018. 62 funds tracked by Wall St. Rank hold SPRO as of Q3 2026.
- Steven Cohen held 14,639 shares of Spero Therapeutics worth $17.7K as of Q3 2026.
- Steven Cohen sold 89,738 Spero Therapeutics shares in Q3 2026, an estimated $122K.
- Spero Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3811 holding.
- Steven Cohen first reported a position in Spero Therapeutics in Q3 2018 and has held it in 5 quarters since.
- Steven Cohen's Spero Therapeutics position peaked at $462K in Q3 2018.
- 62 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.